مباشر

Clinical OMICsProtein Biomarkers in Practice: Strategies to Reduce Drug Development Risk Clinical OMICsMayo Clinic’s REDMOD AI Doubles Early Detection Sensitivity in Pancreatic Cancer FierceBiotechIpsen scuttles liver disease candidates from $952M Albireo acquisition AmgenBiopharma Manufacturing Expands in the U.S.: Amgen, Lilly Double Down on Capacity and Next-Gen Production - BioPharm International Endpoints NewsAmgen, AbbVie say IRA negotiations impacted Q1 sales Clinical OMICsAt-Home Blood Test Screens for Early Dementia Clinical OMICsGlioblastoma: Testosterone Supplements Linked to 38% Lower Risk of Death Endpoints NewsLilly plans new $4.5B manufacturing investment in Indiana Endpoints NewsBeOne culls five cancer programs and an autoimmune Phase 2 Endpoints NewsLonza looks to ride ADC wave with upcoming factory, workforce expansion FierceBiotechBipartisan PRIMATE Act aims to ban monkey imports to US Clinical OMICsEarly Glucagon Elevation Linked to MASLD in Type 2 Diabetes

الأرشيف

الأحدث الأقدم مسح

@Cell

الإجمالي 3

المصدر Cell

بحث --

Cell ١٨ مارس ٢٠٢٦

Deep-learning-based <em>de novo</em> discovery and design of therapeutics that reverse disease-associated transcriptional phenotypes

Cell ٢٥ نوفمبر ٢٠٢٥

A <em>de novo</em>-originated gene drives rose scent diversification

#Junzhong Shang #Yaqi Sui

Cell ٢٥ نوفمبر ٢٠٢٥

<em>De novo</em> design of a peptide modulator to reverse sodium channel dysfunction linked to cardiac arrhythmias and epilepsy

#Ryan Mahling #Bence Hegyi